LINC02458: A Potential Drug Target and Biomarker (G728084)

Target Name: LINC02458

NCBI ID: G728084

LINC02458

Other Name(s): Long intergenic non-protein coding RNA 2458 | long intergenic non-protein coding RNA 2458

LINC02458: A Potential Drug Target and Biomarker

LINC02458 is a non-coding RNA (ncRNA) molecule that has been identified using RNA sequencing (RNA-seq) data. It is located within the genomic region between the UTR3 and UTR4 exons of the human transcriptome. Although LINC02458 is not a protein, it is known to play a role in gene regulation and has been associated with various cellular processes.

The search for potential drug targets and biomarkers is an ongoing process in the field of pharmacology. These targets are molecules that have been identified as potential drug targets and can be targeted by small molecules or other therapeutic agents to induce specific cellular responses. Biomarkers are molecules that are derived from within the body and can be used as indicators of disease or therapeutic progress.

In the context of LINC02458, its potential as a drug target and biomarker becomes an intriguing query. Although more research is needed to fully understand its function, the data available so far suggests that LINC02458 may be a promising target for small molecules.

LINC02458: A Potential Drug Target

The identification of potential drug targets is an important step in the development of new therapeutic agents. Drug targets are molecules that are involved in cellular processes that are targeted by small molecules, such as drugs. In the case of LINC02458, it is not a protein but it is known to play a role in gene regulation, which is an important process in the development and function of cells.

Gene regulation is a complex process that involves the regulation of gene expression by various factors, including RNA factors. LINC02458 has been shown to play a role in the regulation of gene expression by RNA factors, such as microRNA (miRNA) and long non-coding RNAs (lncRNA).

LINC02458 has been shown to interact with several miRNAs, including miR-202 and miR-30. These interactions have been shown to alter the expression of target genes, including the involved in cell adhesion, cell cycle progression, and apoptosis.

Additionally, LINC02458 has also been shown to interact with lncRNA SIRPa. SIRPa is a known RNA factor that interacts with several proteins, including LINC02458. These interactions have been shown to regulate the expression of target genes involved in cell adhesion, migration and invasion.

These findings suggest that LINC02458 may be a potential drug target that can be targeted by small molecules to induce specific cellular responses.

LINC02458: A Potential Biomarker

In addition to its potential as a drug target, LINC02458 may also be a useful biomarker for the diagnosis and monitoring of diseases. The identification of biomarkers is an important aspect of disease diagnosis and treatment, as they can provide insight into the underlying biological mechanisms of a disease and help to identify potential therapeutic approaches.

LINC02458 has been shown to be expressed in various tissues and cells, including brain, heart, liver, and pancreas. This suggests that it may be a potential biomarker for a range of diseases, including neurological and endocrine disorders.

Additionally, the expression of LINC02458 has been shown to be regulated by several factors, including miRNA and lncRNA. These factors may be involved in the regulation of its expression and could be potential targets for small molecules that are associated with the regulation of gene expression.

Conclusion

In conclusion, the data available so far suggests that LINC02458 may be a promising drug target and biomarker. Further research is needed to fully understand its function and its potential as a therapeutic agent.

Protein Name: Long Intergenic Non-protein Coding RNA 2458

The "LINC02458 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02458 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets